Titlebook: Local Therapies for Glioma; Present Status and F M. Westphal,J.-C. Tonn,Z. Ram Conference proceedings 2003 Springer-Verlag Wien 2003 Surger

Nefarious

Intralesional radioimmunotherapy in the treatment of malignant glioma: clinical and experimental fiar matrix-glycoprotein, which is expressed in high amounts in malignant gliomas. We report side effects and survival time of 46 patients, treated after surgical resection and conventional radiotherapy with intralesionally injected labelled (131-Iodine) antibodies to tenascin.

commune

negotiable

https://doi.org/10.1007/978-3-7091-6090-9Surgery; brain; brain tumour; glioma; neurosurgery; radiosurgery; radiotherapy; surgical oncology

Preserve

Acta Neurochirurgica Supplementhttp://image.papertrans.cn/l/image/587720.jpg

擋泥板

Emasculate

maverick

recede

Intracavitary Chemotherapy for Glioblastoma: Present Status and Future Directions,ment is a fundamental characteristic and antagonistic to this endeavour. The typically local recurrence of glioblastoma in about 80% of the cases has prompted intracavitary treatments of which presently only a biodegradable wafer containing carmustine has shown statistically significant benefit regarding survival in three phase III trials.

OGLE

知識(shí)

Interstitial stereotactic radiosurgery,Stereotactic radiosurgery by means of interstitial application of either radionuclides or radiation devices has been used extensively in primary and secondary brain tumors. A few centers have gained sufficient expertise and clinical data to scientifically evaluate this treatment modality.